Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / BlackThorn Therapeutics / Neumora Therapeutics
target Processed

BlackThorn Therapeutics & Neumora Therapeutics

2 shared events · Importance 3 · Last updated Feb 27, 2025

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Relationship Summary

BlackThorn Therapeutics was acquired by Neumora Therapeutics in September 2020, transferring its clinical assets including Navacaprant to the acquirer.

Shared Events (2)
55
Business
Neumora Therapeutics IPO Class Action
BlackThorn Therapeutics: BlackThorn Therapeutics' original Phase Two Trial inclusion criteria were allegedly amended by Neumora Therapeutics to justify its Phase Three Program, which is a key point in the class action lawsuit.
Neumora Therapeutics: Neumora Therapeutics is the defendant in a class action lawsuit alleging false and misleading statements in its IPO Offering Documents, which could lead to significant financial penalties and reputational damage.
Feb 07, 2025 · 6 articles
45
Business
Neumora Therapeutics Securities Class Action
BlackThorn Therapeutics: BlackThorn Therapeutics' original Phase Two trial inclusion criteria were allegedly amended by Neumora Therapeutics to justify its Phase Three Program for Navacaprant.
Neumora Therapeutics: Neumora Therapeutics is the defendant in a securities class action lawsuit, accused of making misleading statements in its IPO offering documents regarding its Phase Two Trials and the therapeutic candidate Navacaprant.
Feb 11, 2025 · 56 articles
NEWSDESK
Explore this relationship live

Track how BlackThorn Therapeutics and Neumora Therapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.